US FDA was set to make EUA data public for COVID-19 vaccines.
The United States Food and Drug Administration (US FDA) on Tuesday said that it would make public reviews of all data and information about the emergency use authorization (EUA) granted to COVID-19 vaccines.
In a statement, US FDA Commissioner Stephen Hahn said that the transparency action was just one of a number of steps they’re taking in order to ensure public confidence in their emergency use authorization review process for biological products, especially for any potential COVID-19 vaccines.
Hahn also said that all FDA drug and biological product centers intended, to the “extent appropriate and permitted by law”, to share information aregarding the scientific review documents supporting the issuance, revision, or revocation of emergency use authorizations.
READ ALSO: Pfizer ‘Very Close’ To Applying For Emergency Use Approval — CEO
Countries worldwide were racing to develop COVID-19 treatments and vaccines, and the rapid pace of development has had experts and doctors concerned about regulatory reviews and transparency.
The Food and Drug Administration said that it recognized disclosing such information would also contribute to the public’s confidence in the agency’s careful review of scientific data.
Moreover, Hanh said that they would also continue to follow the science and to ensure that science remained the “driver of the agency’s regulatory decision-making” in their fight against the coronavirus disease (COVID-19) and beyond on behalf of public health.
Meanwhile, Phizer CEO Albert Bourla told medical news that they’re “very close” to submitting for an EUA, adding that they were set to announce it as soon as they’re doing it.
For more news and updates, you may feel free to visit this site more often. You may also visit Newspapers.ph via the official Facebook page and YouTube channel.